M2ES 60mg

DRUG2 trials

Sponsors

Protgen Ltd

Conditions

Advanced Solid TumorsPancreatic Cancer

Phase 1

Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure

Protgen LtdPancreatic Cancer

Start: 2010-08-31End: 2011-12-31Target: 24Updated: 2010-10-28

Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors

Protgen LtdAdvanced Solid Tumors

Start: 2009-09-30End: 2011-06-30Target: 24Updated: 2010-10-21